Chemical modulators of immune checkpoints and therapeutic use
US10562864B2 · kind B2 · utility
11Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 2018 |
| Grant date | Feb 18, 2020 |
| Priority date | — |
| Expiry date | Nov 14, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/3955
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and pharmaceutical compositions that down-regulate immune checkpoints such as PD-1, PD-L1 and CTLA-4 are provided. Also provided are methods of treating a disease by down-regulating immune checkpoints such as PD-1, PD-L1 and CTLA-4. The methods are useful for treating cancer and viral infection in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.